European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease

Abstract Aims The aim of this survey is to analyze how current recommendations on valvular heart disease (VHD) management have been adopted. Identifying potential discrepancies between recommendations and everyday clinical practice would enable us to better understand and address the remaining challenges in this controversial and complex field. Methods and results A total of 33 questions, distributed via email to all European Society of Cardiology (ESC) affiliated countries through the newsletter of the ESC council on VHD, were answered by 689 respondents, mainly from tertiary care settings. The results of this survey showed that VHD patients are mostly managed by tertiary care centres, where multi-disciplinary heart teams are frequently a reality. Cardiac computed tomography (CT) is often used in the preprocedural planning of transcatheter interventions, particularly for sizing and deliverability assessment. Echocardiography represents the most widely used imaging modality in the diagnostic, intra-operative and follow-up phase of VHD patients. Cardiac magnetic resonance (CMR) is still largely underused, also for conditions such as mitral annular disjunction, or for the assessment of left ventricle volumes where it is considered as the gold standard, despite 3D volumes by echocardiography having proved good comparability with CMR. As for endocarditis, despite still underused, transesophageal echocardiography (TEE) represents the approach of choice for the diagnosis of native and prosthesis valve endocarditis (up to 46% of the respondents use it). In this context, positron emission tomography-CT is largely underused. Conclusion There is widespread adoption of current recommendation on the evaluation of VHD and these are frequently used to guide patient management. Nonetheless, there are still many discrepancies across centres and countries which need to be addressed with the aim of improving patients’ management and outcomes and ultimately positively impacting on healthcare resources.

[1]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[2]  José Ribeiro,et al.  The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. , 2021, European heart journal cardiovascular Imaging.

[3]  Manisha Pandey,et al.  Rheumatic heart disease: A review of the current status of global research activity. , 2020, Autoimmunity reviews.

[4]  Meixiang Xiang,et al.  Burden of valvular heart disease, 1990-2017: Results from the Global Burden of Disease Study 2017 , 2020, Journal of global health.

[5]  Jeroen J. Bax,et al.  Sex differences in bicuspid aortic valve disease. , 2020, Progress in cardiovascular diseases.

[6]  O. Alfieri,et al.  Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. , 2019, European heart journal.

[7]  C. Kwok,et al.  Mitral annular disjunction: A systematic review of the literature , 2019, Echocardiography.

[8]  L. Køber,et al.  Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  Jeroen J. Bax,et al.  Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint. , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[11]  M. Sitges,et al.  Valvular Heart Disease Epidemics. , 2016, The Journal of heart valve disease.

[12]  Susanna Price,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[13]  C. Arden,et al.  How should specialist competencies in heart valve disease be recognized? , 2015, QJM : monthly journal of the Association of Physicians.

[14]  J. Zamorano,et al.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.

[15]  B. Prendergast,et al.  ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences. , 2013, European heart journal.

[16]  J. Carapetis Rheumatic heart disease in developing countries. , 2007, The New England journal of medicine.

[17]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.